Biosimilar
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26